Ind-Swift Laboratories Limited — Statement of deviation(s) or variation(s) under Reg. 32

Ind-Swift Laboratories has informed stock exchanges about a deviation or variation as required under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. This regulation mandates listed companies to promptly disclose any material information that may affect their share price or the market's perception of the company.

This disclosure is a routine compliance requirement and does not necessarily indicate a specific financial event. However, it signals that the company has updated the exchange with a material development. Investors should monitor the full disclosure to understand the nature of the variation and its potential impact on the company's operations or financials.

Investors should wait for the complete statement to be made public. The specific details of the deviation will clarify the context. Until then, the stock price may experience minor volatility. It is advisable to keep an eye on the company's official filings for further clarity.